Abeona Therapeutics resubmits FDA application for gene therapy By Investing.com
CLEVELAND - Abeona Therapeutics Inc. (NASDAQ:), a clinical-stage biopharmaceutical firm, introduced as we speak the resubmission of its Biologics License ...
Tag: Abeona
